Short Bowel Syndrome

Gastroenterology ยท Specialty and rare-disease access

About Short Bowel Syndrome

Short Bowel Syndrome is a condition within gastroenterology commonly requiring specialty therapy. Named Patient Program access may be available for patients in countries where specific therapies are not registered.

Access to specialty treatment

Patients with Short Bowel Syndrome living in countries where their prescribed treatment is not registered or not reimbursed can explore Named Patient Program access. Reserve Meds coordinates this pathway: we work with your physician, help prepare destination-country documentation, and source the drug from DSCSA-compliant US wholesalers.

What to discuss with your physician

  • Whether a specific US-approved drug is clinically appropriate for your case.
  • Whether your treating physician can issue a prescription for NPP access.
  • What documentation your destination country requires for the specific drug.
  • Any dose, monitoring, or administration considerations.

Start a request

Request a drug for Short Bowel Syndrome

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (dispensed by Altima Care, US-licensed specialty pharmacy) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp